Lifitegrast is an N-acyl-L-alpha-amino acid compound that acts as a lymphocyte function-associated antigen-1 (LFA-1) antagonist. It is used as a pharmaceutical raw material in the manufacturing of products for dry eye syndrome.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1025967-78-5
3-(aminomethyl)-5-methylhexanamide
pharmaceutical raw material
(+)-tetrabenazine
pharmaceutical raw material
Pantoprazole sulfide
pharmaceutical raw material
Pantoprazole
pharmaceutical raw material
R-Lifitegrast
pharmaceutical raw material
(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid
JFOZKMSJYSPYLN-QHCPKHFHSA-N
CS(=O)(=O)C1=CC=CC(=C1)C[C@@H](C(=O)O)NC(=O)C2=C(C=C3CN(CCC3=C2Cl)C(=O)C4=CC5=C(C=C4)C=CO5)Cl